Validated using a knockout cell line
Recombinant
RabMAb

Anti-FGFR1 antibody [EPR806Y] (ab76464)

Publishing research using ab76464? Please let us know so that we can cite the reference in this datasheet.

ab76464 has been referenced in 7 publications.

  • Tavasoli M  et al. Both CLIC4 and CLIC5A activate ERM proteins in glomerular endothelium. Am J Physiol Renal Physiol 311:F945-F957 (2016). PubMed: 27582103
  • Delpuech O  et al. Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547. Mol Cancer Ther 15:2802-2813 (2016). PubMed: 27550940
  • Cheng C  et al. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma. Am J Hum Genet 98:256-74 (2016). WB . PubMed: 26833333
  • Chen PY  et al. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest 125:4514-28 (2015). WB . PubMed: 26517696
  • Zhang J  et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602-12 (2013). WB . PubMed: 23583981
  • Zhang J  et al. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models. Clin Cancer Res 18:6658-67 (2012). PubMed: 23082000
  • Tomlinson DC & Knowles MA Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am J Pathol 177:2379-86 (2010). PubMed: 20889570

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up